What are Clinical Practice Guidelines and How are They Developed?
Learn how experts develop and refine MBC treatment guidelines using evidence from MBC clinical trials.
Who are Clinical Trial Research Team Members?
Click to learn about members of the clinical trial research team you will encounter when you are considering and/or participating in a clinical trial and what they do.
What to Know About MBC Treatment-Related Heart Problems
Some MBC treatments can cause or increase the risk of heart problems. Read more about research studying how to monitor and treat cardiotoxicity.
What are Non-Treatment Trials and Why are They Important?
Many clinical trials study ways to improve quality of life, manage side effects, and advance cancer research. Learn more here.
Black Wo(Men) Speak Symposium 2022
Click for an overview of information from the symposium highlighting the need for increased diversity in clinical trials.
What is Stable Disease and How is it Monitored?
Read about stable disease and current research on monitoring MBC treatment response.
Assembling a Healthcare Team That Hears and Respects You
Your voice is important in making decisions about your care, which may include clinical trials. Learn more here about assembling your healthcare team and the importance of your voice in decision-making.
Clinical Trial Participation: The Patient’s Journey
Participating in a clinical trial is a process with many steps. Learn more about what to expect during each step of your clinical trial journey.
Metastatic Trial Search Featured in Clinical Trials Webinar
Watch this video for an overview of breast cancer clinical trials, the importance of diversity in trials, as well as a demonstration of Metastatic Trial Search.
Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
In part 3 of a 3-part series, learn about biomarkers that require more research before being recommended to guide treatment decisions.